Drug Profile
A 192621
Latest Information Update: 04 Feb 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Anti-ischaemics
- Mechanism of Action Endothelin B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified